featured
Secukinumab Safe and Effective for Moderate to Severe Plaque Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Secukinumab Long-Term Safety Experience: A Pooled Analysis of 10 Phase II and III Clinical Studies in Patients With Moderate to Severe Plaque Psoriasis
J Am Acad Dermatol 2016 May 12;[EPub Ahead of Print], PC van de Kerkhof, CE Griffiths, K Reich, CL Leonardi, A Blauvelt, TF Tsai, Y Gong, J Huang, C Papavassilis, T FoxFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.